Physician profile
Ashish Aneja
NPI 1427011493
$76,683.24
in general payments reported to CMS, 2019-2025
5 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.51 · 2021: $8,201 · 2022: $35K · 2023: $13K · 2024: $8,974 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $5,755 · Food and Beverage: $1,166 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $600 · Travel and Lodging: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,505.00 |
| Consulting Fee | $5,755.00 |
| Food and Beverage | $1,165.53 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $600.00 |
| Travel and Lodging | $480.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $60,766.47 | 2021-2025 | Camzyos |
| Medtronic, INC. | $9,521.58 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $6,027.68 | 2021-2022 | |
| Celgene Corporation | $300.00 | 2022 | |
| Canon Medical Systems USA, INC. | $67.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Aneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.